Weight Loss & Wellbeing Clinic Opens in Cardiff

New Weight Loss & Wellbeing Clinic Opens in Cardiff at Pro Sports Medicine

Pro Sports Medicine, Cardiff’s leading sports medicine and orthopaedic performance clinic, has launched a new Weight Loss & Wellbeing Clinic offering clinically supervised weight loss injections, including Tirzepatide (Zepbound® / Mounjaro®)** and Semaglutide (Wegovy® / Ozempic®), designed to support patients both before and after orthopaedic surgery.

The clinic expands Pro Sports Medicine’s existing high-quality services — long known for elite-standard sports medicine, physiotherapy and advanced rehabilitation — to include evidence-based metabolic health and surgical optimisation support.

—

Why This Matters for Orthopaedic Patients in Cardiff

Excess body weight is a significant factor that can influence joint stress, surgical risk and recovery outcomes, especially for procedures such as hip, knee and spinal surgery. Research and clinical guidance now recognise GLP-1 receptor agonists like tirzepatide and semaglutide as effective medical treatments for weight management when prescribed and monitored by healthcare professionals.

Patients preparing for surgery can benefit from metabolic optimisation — including reduced mechanical load on vulnerable joints, improved mobility and enhanced resilience to surgical stress — while those in the post-operative phase may see better wellbeing and long-term functional outcomes.

—

What the New Clinic Offers

The Weight Loss & Wellbeing Clinic at Pro Sports Medicine Cardiff provides:

• Medical assessment and personalised care plans
• Prescription-only weekly injections of tirzepatide (Zepbound/Mounjaro).
• Ongoing clinical monitoring and dose adjustment
• Integration with orthopaedic rehabilitation and physiotherapy
• Support for lifestyle and metabolic wellbeing

All treatments are delivered within a qualified medical supervision model, ensuring safety and compliance with current UK prescribing and clinical governance standards.

—

Effective, Evidence-Led Weight Management

Both tirzepatide and semaglutide are licensed for weight management in adults with obesity or weight-related health conditions when used alongside lifestyle modification. Semaglutide, administered once weekly, has been shown to significantly reduce appetite and support meaningful weight loss, while tirzepatide influences multiple hormone pathways to further enhance metabolic results.

These treatments are not suitable for everyone, and eligibility is assessed on an individual basis, with a full consultation required before any prescription is provided.

—

Expanding Health Services in Cardiff

This new clinic reflects Pro Sports Medicine’s commitment to evolving patient-centred care in Cardiff. Established in 2008 and widely recognised for its sports medicine, physiotherapy and bespoke orthopaedic support services, Pro Sports Medicine continues to bring advanced clinical care to the local community. 

Whether you’re preparing for orthopaedic surgery, planning post-operative recovery, or seeking medically supervised weight management, the clinic offers a comprehensive pathway grounded in clinical expertise and safety.

—

Notes for Patients

* Prescription weight loss medications are available only after appropriate medical assessment.
* These medications are used in combination with diet, exercise and clinical monitoring — not as standalone treatments.
* Not all patients will be suitable candidates.